Home
|
Learning Center
|
中文版
Publications
站内成果搜索:
搜索
Oral Anticoagulation After Successful Atrial Fibrillation Ablation Operations: Is It Necessary?
Oral administration of amphotericin B nanoparticles: antifungal activity, bioavailability and toxicity in rats
Oral acute and subchronic toxicity studies of the oil extracted from pequi (Caryocar brasiliense, Camb.) pulp in rats
Oral mite anaphylaxis mimicking acute asthma
Oral delivery of liposomes
Oral leptin supplementation throughout lactation in rats prevents later metabolic alterations caused by gestational calorie restriction
Oral treatment with zinc sulfate increases the expression of Th1 cytokines mRNA in BALB/c mice infected with Leishmania major
Oral complications in irradiated head and neck cancer patients-3D conformal radiotherapy planning vs. 3D conformal radiotherapy planning with magnetic resonance fusion
Oral Drugs for Unexplained Infertility
Oral Anticoagulant Agents in Patients With Atrial Fibrillation and Heart Failure Does Heart Failure Status Influence Efficacy and Safety?
Oral subchronic exposure to silver nanoparticles causes renal damage through apoptotic impairment and necrotic cell death
Oral fluid versus blood sampling in group-housed sows and finishing pigs: Feasibility and performance of antibody detection for porcine reproductive and respiratory syndrome virus (PRRSV)
Oral iron for anaemia in non-dialysis chronic kidney disease. The relationship between hepcidin-25, iron metabolism and inflammation.
Oral Nutrient Supplementation and Cognitive Function RESPONSE
Oral health-related quality of life and associated factors in a care-dependent and a care-independent older population
Oral health-related quality of life and implant therapy: A prospective multicenter study of preoperative, intermediate, and posttreatment assessment
Oral inflammation and infection, and chronic medical diseases: implications for the elderly
Oral Targeted Therapies and Central Nervous System (CNS) Metastases
Orally available stilbene derivatives as potent HDAC inhibitors with antiproliferative activities and antitumor effects in human tumor xenografts
Oral Delivery of a Novel Recombinant Streptococcus mitis Vector Elicits Robust Vaccine Antigen-Specific Oral Mucosal and Systemic Antibody Responses and T Cell Tolerance (vol 10, e0143422, 2015)
Oral pathology in inflammatory bowel disease
Oral healthcare management in Bardet Biedl syndrome
Oral and transdermal drug delivery systems: role of lipid-based lyotropic liquid crystals
Oral Anticoagulants Initiation in Patients with A trial Fibrillation: Real-World Data from a Population-Based Cohort
Oral Microbiota: Microbial Biomarkers of Metabolic Syndrome Independent of Host Genetic Factors
Oral Fosfomycin and Prostatitis
Oral appliances for managing sleep bruxism in adults: a systematic review from 2007 to 2017
Oral propranolol for infantile hemangiomas: a prospective study on the role of 48-hour Holter monitoring in additional safety assessment
Oral Aripiprazole as Maintenance Treatment in Adolescent Schizophrenia: Results From a 52-Week, Randomized, Placebo-Controlled Withdrawal Study
Oral Glutamine Supplementation Protects Female Mice from Nonalcoholic Steatohepatitis
Oral versus intravenous high-dose methylprednisolone for treatment of relapses in patients with multiple sclerosis (COPOUSEP): a randomised, controlled, double-blind, non-inferiority trial (vol 386, pg 974, 2015)
Oral versus intravenous high-dose methylprednisolone for treatment of relapses in patients with multiple sclerosis (COPOUSEP): a randomised, controlled, double-blind, non-inferiority trial (Lancet 2015; 386: 974-981)
Oral corticosteroids for multiple sclerosis relapse
Oral rather than intravenous corticosteroids should be used to treat MS relapses - No
Oral and intravenous steroids for multiple sclerosis relapse: a systematic review and meta-analysis
Oral rather than intravenous corticosteroids should be used to treat MS relapses - Yes
Oral azithromycin given during labour decreases bacterial carriage in the mothers and their offspring: a double-blind randomized trial
Oral tranexamic acid (TA) in the treatment of melasma: A retrospective analysis
Oral health guidelines in humanitarian settings
Oral manifestations of Japanese patients with osteogenesis imperfecta